T Cell Lymphomas

MD IQ

Conference Coverage

Phase III trial: VZV protects auto-HCT patients

ORLANDO – An inactivated VZV vaccine for adults undergoing autologous hematopoietic stem cell transplantation has proven safe and effective.

Pages